Cargando…

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

Epstein–Barr virus (EBV) is a human herpesvirus that is common among the global population, causing an enormous disease burden. EBV can directly cause infectious mononucleosis and is also associated with various malignancies and autoimmune diseases. In order to prevent primary infection and subseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Cong, Chen, Xin-chun, Kang, Yin-feng, Zeng, Mu-sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218244/ https://www.ncbi.nlm.nih.gov/pubmed/34168649 http://dx.doi.org/10.3389/fimmu.2021.677027

Ejemplares similares

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses
por: Kong, Xiang-Wei, et al.
Publicado: (2022)

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
por: Jean-Pierre, Vincent, et al.
Publicado: (2021)

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
por: Cui, Xinle, et al.
Publicado: (2021)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Cardiovascular involvement in Epstein–Barr virus infection
por: Chen, Xinying, et al.
Publicado: (2023)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

GATA2 Deficiency and Epstein–Barr Virus Disease
por: Cohen, Jeffrey I.
Publicado: (2017)

Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients
por: Yin, Yi-Xin, et al.
Publicado: (2022)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren’s Syndrome
por: Xuan, Jingxiu, et al.
Publicado: (2020)

Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
por: Münz, Christian
Publicado: (2017)

Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
por: Jog, Neelakshi R., et al.
Publicado: (2021)

Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus
por: Xia, Wei, et al.
Publicado: (2022)

Design of a multi-epitopic vaccine against Epstein-Barr virus via computer-based methods
por: Larijani, Amirhossein, et al.
Publicado: (2023)

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
por: Hui-Yuen, Joyce, et al.
Publicado: (2011)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
por: Ruiz-Pablos, Manuel, et al.
Publicado: (2021)

Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
por: Zhang, Hui, et al.
Publicado: (2022)

Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection
por: Hedström, Anna Karin
Publicado: (2023)

Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies
por: Han, Shuting, et al.
Publicado: (2021)

Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)

Epstein–Barr Virus(+) Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders
por: Magg, Thomas, et al.
Publicado: (2018)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
por: Latour, Sylvain, et al.
Publicado: (2018)

Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis?
por: Hassani, Asma, et al.
Publicado: (2019)

The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog
por: Long, Heather M., et al.
Publicado: (2019)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven
por: Cirac, Ana, et al.
Publicado: (2021)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
por: Balfour, Henry H., et al.
Publicado: (2022)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Adoptive T Cell Therapy for Epstein–Barr Virus Complications in Patients With Primary Immunodeficiency Disorders
por: McLaughlin, Lauren P., et al.
Publicado: (2018)

Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes
por: Jog, Neelakshi R., et al.
Publicado: (2018)

Pathologically Relevant Mouse Models for Epstein–Barr Virus–Associated B Cell Lymphoma
por: Huang, Shiyu, et al.
Publicado: (2021)

Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility
por: Lopez-Rivera, Daniela Olivia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tj97g7vnl7f99o9vo2u0gpjau